Log in to save to my catalogue

Supraphysiological androgens suppress prostate cancer growth through androgen receptor-mediated DNA...

Supraphysiological androgens suppress prostate cancer growth through androgen receptor-mediated DNA...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6763228

Supraphysiological androgens suppress prostate cancer growth through androgen receptor-mediated DNA damage

About this item

Full title

Supraphysiological androgens suppress prostate cancer growth through androgen receptor-mediated DNA damage

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2019-10, Vol.129 (10), p.4245-4260

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

Prostate cancer (PC) is initially dependent on androgen receptor (AR) signaling for survival and growth. Therapeutics designed to suppress AR activity serve as the primary intervention for advanced disease. However, supraphysiological androgen (SPA) concentrations can produce paradoxical responses leading to PC growth inhibition. We sought to disce...

Alternative Titles

Full title

Supraphysiological androgens suppress prostate cancer growth through androgen receptor-mediated DNA damage

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6763228

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6763228

Other Identifiers

ISSN

0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI127613

How to access this item